摘要
目的研究分析沙格列汀和二甲双胍缓释片在临床中治疗2型糖尿病患者的效果以及特点。方法选择2017年2月至2018年2月到我院进行治疗的80例2型糖尿病患者,随机平均分为对照组、观察组,分别40例。予以对照组行二甲双胍缓释片进行治疗,予以观察组行沙格列汀和二甲双胍缓释片进行治疗,比较治疗后的效果以及血糖水平指标变化情况。结果两组患者治疗前,空腹血糖以及餐后2h血糖、糖化血红蛋白指标水平比较(P>0.05);治疗后观察组上述指标均显著优于对照组(P<0.05)。观察组临床总有效率(87.5%)显著优于对照组(75.0%)(P<0.05)。结论在治疗2型糖尿病患者的时候,选择沙格列汀和二甲双胍缓释片进行治疗,可有效控制血糖情况,促进康复,临床医疗价值可观。
Objective To study the effects and characteristics of saxagliptin and metformin sustained-release tablets in patients with type 2 diabetes. Methods 80 patients with type 2 diabetes who were treated in our hospital from February 2017 to February 2018 were random Ly divided into control group and observation group, with 40 cases in each group. The control group was treated with metformin sustained-release tablets. The observation group was treated with saxagliptin and metformin sustained-release tablets. The effect after treatment and changes in blood glucose levels were compared. Results Before treatment, fasting blood glucose and 2 h postprandial blood glucose and glycosylated hemoglobin were compared before and after treatment（P〈0.05）. The above indicators in the observation group were significantly better than those in the control group after treatment（P〈0.05）. The total clinical effective rate（87.5%） in the observation group was significantly better than that in the control group（75.0%）（P〈0.05）. Conclusion In the treatment of type 2 diabetes patients, the choice of saxagliptin and metformin sustained-release tablets for treatment, can effectively control blood glucose conditions, promote rehabilitation, clinical medical value is considerable.
作者
施福明
SHI Fu-ming(Linyuan Hospital in Datong District,Daqing,Heilonggjiang,163813)
出处
《智慧健康》
2018年第14期99-100,共2页
Smart Healthcare
关键词
二甲双胍缓释片
2型糖尿病
沙格列汀
Metformin sustained-release tablets
Type 2 diabetes
Saxagliptin
